NI
FPRX

Numeric Investors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Numeric Investors’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-34,900
Closed -$1.75M – 1208
2016
Q4 		$1.75M Buy
34,900
+15,600
+81% +$820K 0.02% 531
2016
Q3 		$1.01M Sell
19,300
-203,546
-91% -$9.72M 0.01% 614
2016
Q2 		$9.21M Buy
222,846
+205,746
+1,203% +$8.95M 0.08% 229
2016
Q1 		$695K Sell
17,100
-16,100
-48% -$553K 0.01% 617
2015
Q4 		$1.38M Sell
33,200
-67,300
-67% -$2.26M 0.01% 516
2015
Q3 		$1.55M Sell
100,500
-71,868
-42% -$1.54M 0.02% 449
2015
Q2 		$4.28M Sell
172,368
-104,085
-38% -$2.32M 0.05% 274
2015
Q1 		$6.32M Buy
+276,453
New +$6.98M 0.08% 225
2014
Q4 		– Sell
-46,049
Closed -$540K – 1023
2014
Q3 		$540K Buy
46,049
+22,149
+93% +$279K 0.01% 573
2014
Q2 		$372K Buy
+23,900
New +$343K 0.01% 627

Other funds holding FPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Numeric Investors's FPRX Position: Q1 2017 in Review

Numeric Investors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2017, closing a stake of 34,900 shares — an estimated $1.75M sold.

Numeric Investors first reported a position in FPRX in Q2 2014 and held it in 10 quarters. The position peaked at $9.21M in Q2 2016. 157 funds tracked by Wall St. Rank hold FPRX as of Q1 2017.

  • Numeric Investors reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2017 after selling out during the quarter.
  • Numeric Investors sold 34,900 Five Prime Therapeutics, Inc. shares in Q1 2017, an estimated $1.75M.
  • Numeric Investors first reported a position in Five Prime Therapeutics, Inc. in Q2 2014 and held it in 10 quarters.
  • Numeric Investors's Five Prime Therapeutics, Inc. position peaked at $9.21M in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2017.

Based on Numeric Investors's 13F filing for Q1 2017, filed 15 May 2017.